Alzheimer's Study


Download Alzheimers Brochure

"Everyone did a great job making one feel welcomed!  I had a great time and will be back."
Volunteer

Alzheimer's Study

DESCRIPTION:

A study to see how well an investigational medication is tolerated and how safe it is in individuals who have Mild Alzheimer’s disease with Mild Cognitive Impairment.  Your contributions today may benefit generations to come.  This study is for research purposes only and is not intended to treat a medical condition.  

ABOUT THE DRUG:

This is an investigational medication designed to treat Mild Alzheimer’s with Mild Cognitive Impairment.  

LENGTH OF STUDY:

Screening visit. 

First inpatient stay: 4 days and 3 nights.

Outpatient visits: 5 separate occasions on Day 6, 9, 16, 21, and 42 following the first dose. 

Final visit: 42 days after your fifth outpatient visit. 

The study will last approximately 84 days from the first admission to the final visit.

DATES:
Currently Enrolling

REQUIREMENTS:

  • Ages 50 years and older
  • Males or Females
  • Diagnosis of Mild Alzheimer’s Disease with Mild Cognitive Impairment
COMPENSATION:

Qualified participants will receive up to $1,200; Project partners will also receive up to an additional $680

Login